 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 2309 | 回復(fù): 11 | |||||
| 當前只顯示滿足指定條件的回帖，點擊這里查看本話題的所有回帖 | |||||
[交流]
GSK被調(diào)查，會對醫(yī)藥行業(yè)各個產(chǎn)業(yè)鏈產(chǎn)生什么影響 已有11人參與
|
|||||
| 大家都來深入淺出的分析一下 |
回復(fù)此樓» 收錄本帖的淘帖專輯推薦
 新藥研發(fā)必備資料 | 行業(yè)動態(tài) |
» 猜你喜歡
基于AI智能算法的裝備結(jié)構(gòu)可靠性分析與優(yōu)化設(shè)計技術(shù)
已經(jīng)有0人回復(fù)
-
求助求助
已經(jīng)有0人回復(fù)
-
藥物學論文潤色/翻譯怎么收費?
已經(jīng)有78人回復(fù)
-
農(nóng)業(yè)資源與環(huán)境、智慧農(nóng)業(yè)專業(yè)本科生畢業(yè)論文課題選題求助
已經(jīng)有1人回復(fù)
-
人工智能賦能聚合物及復(fù)合材料模型應(yīng)用與實踐
已經(jīng)有0人回復(fù)
-
各國和國際組織現(xiàn)行藥典注射用水質(zhì)量標準
已經(jīng)有0人回復(fù)
-
求助用微譜數(shù)據(jù)庫查詢
已經(jīng)有0人回復(fù)
-
計算化學與人工智能驅(qū)動的MOFs性能預(yù)測與篩選技術(shù)
已經(jīng)有0人回復(fù)
-
研三實驗求指導(dǎo)
已經(jīng)有0人回復(fù)
-
金屬材料多尺度計算模擬技術(shù)與應(yīng)用：微觀機理到宏觀性能的集成工作
已經(jīng)有0人回復(fù)
-
江西科技師范大學微生物天然藥物老師介紹
已經(jīng)有23人回復(fù)
» 本主題相關(guān)商家推薦: (我也要在這里推廣)
cpuyou
鐵桿木蟲 (職業(yè)作家)
圣行者
- 應(yīng)助: 82 (初中生)
- 金幣: 9903.5
- 紅花: 19
- 帖子: 3698
- 在線: 815.7小時
- 蟲號: 840835
- 注冊: 2009-09-05
- 性別: GG
- 專業(yè): 藥劑學
7樓2013-07-18 16:32:40
cydwood
金蟲 (小有名氣)
- 應(yīng)助: 3 (幼兒園)
- 金幣: 1146
- 帖子: 164
- 在線: 100.3小時
- 蟲號: 536376
- 注冊: 2008-03-30
- 性別: GG
- 專業(yè): 有機合成
2樓2013-07-17 13:17:45
buffalo2012
銀蟲 (小有名氣)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 1957.5
- 帖子: 61
- 在線: 73.8小時
- 蟲號: 1636297
- 注冊: 2012-02-23
- 專業(yè): 細胞信號轉(zhuǎn)導(dǎo)
★
小木蟲: 金幣+0.5, 給個紅包，謝謝回帖
小木蟲: 金幣+0.5, 給個紅包，謝謝回帖
|
柳葉刀文章，轉(zhuǎn)自丁香園，分析GSK事件，說中國醫(yī)患問題可能與醫(yī)生和某些藥企的不健康關(guān)系有關(guān)，請看下文： Doctors and pharma in China The Lancet Doctor—patient relationships in China are in crisis. Doctors have been injured or even killed by patients at work. One of the major drivers might be the unhealthy and unethical relations between many doctors and some drug companies. On July 8, GlaxoSmithKline (GSK) said that they were investigating allegations that its staff had improperly used cash and other incentives to encourage the prescription of onabotulinumtoxin A (Botox) in China. The company added that “inquiries to date have found no evidence of bribery or corruption in relation to our sales and marketing of therapeutic Botox in China.” The Lancet has no evidence to suggest that the allegations against GSK in China are true. However, some observers claim that bribing doctors to boost drug prescriptions by some drug companies is an open secret, and that this alleged practice has compromised the public's trust in doctors. The varieties of unethical relationships that exist between some doctors and some of the drug companies in China are said to range from cash kickbacks, lavish gifts or entertainment, ghost writing services, sponsored supplements in journals, and all-expenses-paid trips. There is real concern that doctors' prescriptions are therefore not based solely on patient need and clinical evidence, but may be biased by commercial interests. The perceived unethical association between physicians and industry in China is worrying, because it inevitably harms patients as well as doctors. It damages the doctor—patient relationship and, ultimately, China's whole health system. The GSK China allegations, although unproven, have clearly rung an alarm bell for China's regulatory authorities to ensure the drug industry promotes products in a responsible, ethical, and professional way. Chinese doctors should rely on evidence-based clinical guidelines to inform their practice, and are in urgent need of guidance on their collaborations with the drug industry in various areas such as patient care, professional education, and research. Furthermore, training for doctors in China on managing their relationships ethically with the drug industry and other organisations should start at medical school and be part of continuing professional education. |
3樓2013-07-17 14:31:18
先是網(wǎng)上報紙上罵聲一片，然后磚家出來澄清，然后。。。。。就沒有然后了。 4樓2013-07-17 14:33:25
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 085701環(huán)境工程，267求調(diào)劑 +15 | minht 2026-03-26 | 15/750 |
|
|---|---|---|---|---|
|
|
[考研] 286求調(diào)劑 +4 | 丟掉懶惰 2026-03-27 | 7/350 |
|
|
|
[考研] 322求調(diào)劑 +6 | 宋明欣 2026-03-27 | 6/300 |
|
|
[考研] 0856，材料與化工321分求調(diào)劑 +8 | 大饞小子 2026-03-27 | 9/450 |
|
|
|
[考研] 學碩274求調(diào)劑 +5 | Li李魚 2026-03-26 | 5/250 |
|
|
|
[考研] 266分求材料化工冶金礦業(yè)等專業(yè)的調(diào)劑 +4 | 哇呼哼呼哼 2026-03-26 | 4/200 |
|
|
|
[考研] 322求調(diào)劑 +4 | 舊吢 2026-03-24 | 4/200 |
|
|
|
[考研] 考研調(diào)劑 +9 | 小蠟新筆 2026-03-26 | 9/450 |
|
|
|
[考研] 材料調(diào)劑 +8 | 匹克i 2026-03-23 | 8/400 |
|
|
|
[考研] 336材料求調(diào)劑 +7 | 陳瀅瑩 2026-03-26 | 9/450 |
|
|
|
[考研] 化學工程085602 305分求調(diào)劑 +17 | RichLi_ 2026-03-25 | 17/850 |
|
|
|
[考研] 0854電子信息求調(diào)劑 324 +4 | Promise-jyl 2026-03-23 | 4/200 |
|
|
|
[考研] 食品專碩 一志愿雙一流 328 +3 | xiaom99 2026-03-21 | 4/200 |
|
|
|
[考研] 307求調(diào)劑 +3 | 余意卿 2026-03-21 | 6/300 |
|
|
|
[考博] 26申博自薦 +3 | whh869393 2026-03-24 | 3/150 |
|
|
|
[考研] 材料/農(nóng)業(yè)專業(yè)，07/08開頭均可，過線就行 +3 | 呵唔哦豁 2026-03-23 | 4/200 |
|
|
|
[考研] 一志愿重慶大學085700資源與環(huán)境，總分308求調(diào)劑 +7 | 墨墨漠 2026-03-23 | 8/400 |
|
|
|
[考研] 315分，誠求調(diào)劑，材料與化工085600 +3 | 13756423260 2026-03-22 | 3/150 |
|
|
|
[考研] 求調(diào)劑 +4 | 要好好無聊 2026-03-21 | 4/200 |
|
|
|
[考研] 一志愿深大，0703化學，總分302，求調(diào)劑 +4 | 七月-七七 2026-03-21 | 4/200 |
|